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Abstract
Optogenetic and chemogenetic control of proteins has revealed otherwise inaccessible facets of 
signaling dynamics. Here we use light or ligand-sensitive domains to modulate the structural 
disorder of diverse proteins, thereby generating robust allosteric switches. Sensory domains were 
inserted into non-conserved, surface exposed loops that were tight and identified computationally 
as allosterically coupled to active sites. Allosteric switches introduced into motility signaling 
proteins (kinases, GTPases, guanine exchange factors) controlled conversion between 
conformations closely resembling natural active and inactive states, and modulated the 
morphodynamics of living cells. Our results illustrate a broadly applicable approach to design 
physiological protein switches.
Proteins have been engineered to respond to light or small molecules in living cells through 
a number of mechanisms, including oligomerization (1–4), control of targeting sequences (1, 
5, 6), split proteins (2), sterically blocking the active site (1, 7, 8), and engineered allosteric 
control (9–13). Engineering allostery has the potential to be especially versatile and 
valuable, as sensory domains can be inserted where they do not interfere with normal protein 
interactions, more readily producing fully functional analogs to replace endogenous protein. 
Allosteric sites have been identified using both screening approaches (10, 14) and rational 
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analysis of sequence conservation (10, 11). A number of domains, including the light-
sensitive LOV2 domain (11) and drug-responsive uniRapR domain (12, 13) used here, have 
been applied. Nonetheless, it remains challenging to identify allosteric sites via rational 
analysis, and to produce reversible, robust allosteric switches whose on and off states 
replicate natural levels of protein activity. Here we present a generalizable approach to 
identify surface loops where the disorder of the attached domain can be effectively 
transferred to the active site in a controlled fashion (harnessing extrinsic disorder (9, 10, 12–
15)), to produce on and off states that mimic naturally occurring protein states.
In previous work, we identified an allosteric site in kinases where insertion of an engineered 
domain (uniRapR) conferred rapamycin-induced kinase activation (12, 13). Insertion of the 
uniRapR domain rendered kinases catalytically inactive until the domain bound rapamycin 
(12, 13, 16). Molecular dynamics simulations indicated that the protein loop containing the 
insertion site was mechanically coupled to the ATP binding site (13). We hypothesized that 
insertion of a light-responsive domain at the same site could lead to optogenetic control of 
kinases (Fig. 1A). We chose the LOV2 domain because the 10 Å spacing between its N and 
C termini enabled us to insert the domain with minimal perturbation into a loop (Fig. 1B) 
that connects parts of a tightly folded structural unit (two interacting anti-parallel β-strands). 
The spacing between LOV2’s termini becomes much more flexible upon irradiation, due to 
disordering of terminal helices (17, 18); this could perturb the conformation of the loop and 
the β-strands. Introducing disorder into the loop would cause protein inhibition, rather than 
the activation caused by rapamycin-induced folding of the uniRapR domain (fig. S1). The 
light-induced conformational changes in LOV2 (3.8 kcal/mol of free energy (19)) should be 
more than sufficient to disorder portions of host proteins (fig. S2), whose overall stabilities 
are on the order of 5–15 kcal/mol (20).
We focused on Src kinase because of evidence that its activity is controlled by spatio-
temporal dynamics in vivo (16, 21). The LOV2 domain was inserted at position G296 of 
constitutively active Src mutant Y535F (YF). We named the new Src analog PI-Src, for 
photo-inhibitable Src. In vitro kinase activity assays revealed that this LOV2-Src fusion was 
indeed strongly inhibited upon exposure to blue light (Fig. 1C). Light had no effect on the 
activity of kinase dead (KD) or constitutively active (YF) Src. Inhibition was not sensitive to 
small variations in linker length (fig. S3). To test PI-Src in living cells, we generated SYF 
cells (cells lacking the Src family members Src, Yes and Fyn expressing PI-Src(YF). 
Phosphotyrosine blots of cell lysates showed that irradiation inhibited phosphorylation of 
multiple Src substrates (Fig. 1C and fig. S4). Consistent with Src’s reported roles in motility 
(13, 16, 21), irradiation reduced migration rates, and caused reversible collapse of 
lamellipodia (fig. S5 and movie S1). Similar effects were produced by the Src inhibitor PP2 
(fig. S5 and movie S2).
To investigate how distortion of the insertion loop led to a reduction in kinase activity, we 
built a structural model of PI-Src, and examined its light-induced conformational changes 
using discrete molecular dynamics (22, 23). While we expected to observe randomly 
distorted conformations of PI-Src in the lit state, we saw instead that the active and inactive 
states of PI-Src were strikingly similar to the crystal structures of active and inactive wild 
type (WT) Src (Fig. 1D, correlation coefficient = 0.82). This suggested that irradiation shifts 
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PI-Src from its physiological active state to a conformation strongly resembling Src’s native 
inactive state (fig. S6).
The physiologically relevant conformations of PI-Src raised the possibility of examining 
how Src controls the motility of living cells. We generated SYF cells expressing PI-
Src(WT). In the dark, PI-Src(WT) showed the perinuclear distribution (Fig. 1E) typical of 
endogenous, inactive Src (16). Upon irradiation, the PI-Src translocated to focal adhesions at 
the cell periphery and induced changes in cell morphodynamics (increased protrusion and 
retraction, polarization and in some cases polarized movement, movie S3). Returning the 
cells to the dark reversed focal adhesion localization (Fig. 1E) but not effects on cell 
morphodynamics (fig. S7). It is thought that Src localization to focal adhesions is mediated 
by Src SH2/SH3 domains, and is not dependent on kinase activity (24, 25). The light-
induced distortion of the catalytic domain that inhibits the kinase may also perturb 
autoinhibitory interactions, exposing the SH2 and SH3 domains; this likely generated the 
reversible focal adhesion localization we observed, and suggested that focal adhesion 
localization was sufficient to affect cell morphodynamics even without catalytic activity. 
Supporting this hypothesis, we found that PI-Src(KD) also translocated reversibly to 
adhesions and induced changes in morphodynamics upon irradiation, and that elimination of 
the SH2 and SH3 domains from PI-Src(KD) prevented both focal adhesion localization and 
effects on cell morphodynamics (fig. S7). Movement away from focal adhesions, which 
occurred 30–40 seconds after irradiation was halted, indicated that the conformational 
change of PI-Src was reversible in cells (fig. S7) and was consistent with LOV2’s rate of 
return to the dark conformation (t1/2 = 18.5 sec at 37°C in cells (26)). In contrast, effects on 
cell morphodynamics were retained for >20 minutes after irradiation was halted, potentially 
due to feedback kinetics and/or inactivation pathways not involving Src.
Controlling protein activity via LOV2 insertion would be much more valuable if it could be 
readily applied to multiple proteins families. We tested a more generalizable approach by 
identifying an allosteric site for LOV2 insertion in the Rho family GTPase Rac1. We 
focused on surface-exposed and evolutionarily non-conserved loops to avoid possible 
structural perturbations, and asked whether these loops were mechanically coupled to the 
active site. For the kinase analogs above, we found that both dynamic coupling analysis (12) 
and a static contact map analysis (fig. S8 and S9) were effective in identifying mechanically-
coupled loops. (The latter offers a simpler approach accessible to many laboratories). 
Dynamic coupling and static contact map analyses indicated several loops in Rac1 (Fig. 2A 
and fig. S10), but much of the surface of Rac1 is used to interact with other proteins, 
limiting the loops appropriate for insertion. Considering all these criteria we selected loop 
L1, which connects β-strands between the S1 and S2 regions (Fig. 2A). L1 was similar to 
the insertion loop of Src in that it connected interacting secondary structures, enabling 
efficient propagation of structural changes from the inserted domain to the host protein. All 
the examples that follow indicate that such ‘tight loops’ are useful insertion sites (fig. S9 and 
S11).
To test the efficacy of LOV2 insertion into the L1 loop, we incorporated the Rac1 analog 
into a previously characterized fluorescence resonance energy transfer (FRET) biosensor of 
Rac1 activity (27) (donor fluorescent protein fused to PI-Rac1 and FRET acceptor fused to a 
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fragment from p21-activated kinase that specifically binds activated Rac1). PI-Rac1 
containing a dark state LOV2 mutation was activated by the upstream guanine exchange 
factor (GEF) Vav2, while activation of a lit state mutant was substantially reduced (Fig. 2B). 
Even when an activating mutation (Q61L) was introduced in Rac1, the lit state LOV2 mutant 
showed strong inhibition (fig S12). For physiologically relevant studies, we used PI-Rac1 to 
replace endogenous Rac1 in Rac1-depleted fibroblasts. Irradiation produced reversible cell 
edge retraction, initially as indentations closely spaced along the edge, and then broad 
retraction of entire lamellae (fig. S12 and movies S4 and S5). We also generated switches 
from the Rho family GTPases RhoA and Cdc42, using insertion in the same loop. Both 
showed effective light-induced inhibition in live cells (Fig. 2B, fig. S13, movies S6 and S7).
To probe the mechanism of photoinhibition, we determined the crystal structure of dark state 
PI-Rac1 and examined lit/dark conformational changes using molecular dynamics. The 
crystal structure showed that LOV2 was placed where it did not interfere with Rac1 binding 
to regulatory or effector proteins (Fig. 2C, fig. S14 and Table S1). Notably, the dark state 
activated structure was almost identical to that of activated WT Rac1, with a root mean 
square deviation (RMSD) of only 0.35 Å (Fig. 2C). Molecular dynamics showed that the 
conformational change between dark and irradiated PI-Rac1 manifested mainly in the S1 
and S2 switch regions, and that the conformational changes of PI-Rac1 and WT Rac1 were 
remarkably similar (Fig. 2D and fig. S15). Together these studies suggested that opto-
allosteric perturbation of Rac1, like Src, caused switching between naturally occurring active 
and inactive states.
We next targeted another protein family, GEFs, beginning with the Rac1 activator Vav2. 
GEFs present a different challenge in that they induce a conformational change through 
GTPase binding to a broad area involving many relatively weak interactions. Computational 
analysis of Vav2’s GTPase-binding DH domain revealed three potential insertion loops (Fig. 
3A and fig. S16). We used loop L4 for LOV2 insertion because it produced the most 
effective switch. PI-Vav2 was tested in living cells by examining its effects on a Rac1 
biosensor (Fig. 3B). The activities of the PI-Vav2 dark and lit state mutants resembled those 
of different activated and inactivated Vav2 mutants (Fig. 3B and figs. S17 and S18). Pull-
down assays confirmed that PI-Vav2 was inhibited upon irradiation (fig. S17), and 
irradiation of PI-Vav2 in HeLa cells produced rapid and reversible retraction (Fig. 3C and 
movie S8). Insertion of LOV2 into L1 or L2 also produced effective PI-Vav2 constructs, but 
insertion of LOV2 into a loop that was not “tight” produced no switch (fig. S18). The same 
analysis was used to create two other photo-inhibitable GEFs: GEF-H1, a Rho GEF, and 
Intersectin1(ITSN), a Cdc42 GEF (Fig. 3D and figs. S19–S21).
Unlike kinase and GTPase catalytic domains, the GEF catalytic domains do not undergo 
major intra-domain conformational changes. Instead, they are regulated sterically by 
autoinhibitory domains. To investigate the light-mediated structural changes of PI-ITSN 
(L2), we determined the crystal structures of PI-ITSN alone and in complex with Cdc42 
(Fig. 3E, fig. S22 and Table S2). PI-ITSN and WT ITSN were structurally similar, with a 
backbone RMSD of 0.37 Å. The structure of Cdc42 in the ITSN:Cdc42 complex, and in the 
PI-ITSN:Cdc42 complex differed with an RMSD of only 0.31 Å. The interface between 
ITSN and Cdc42 was also in excellent agreement in the two structures, with an RMSD of 
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0.36 Å (Fig. 3E). The crystal structure of the PI-ITSN:Cdc42 complex was consistent with 
the shapes of the PI-ITSN:Cdc42 complex and PI-ITSN in solution, constructed ab initio by 
small angle X-ray scattering (fig. S24).
Molecular dynamics simulations of ITSN and PI-ITSN revealed that the motions of helices 
α5 and α6, part of the active site, correlate with the motions of the insertion loop (Fig. 3F), 
and hydrogen/deuterium exchange coupled to mass spectrometry showed light-induced 
destabilization of these helices (Fig. 3F and figs. S24–S26). These results suggest that native 
ITSN and Cdc42 interactions are maintained in PI-ITSN, and support an allosteric 
connection between the insertion loop and important active site residues.
We also inserted the uniRapR domain in GEFs, to activate GEFs with rapamycin. Vav2, 
ITSN, Asef, p115, and Tiam1 all showed rapamycin-induced GTPase binding in pulldown 
assays (fig. S27). Titrating uniRapR-Vav2 with saturating rapamycin in HEK293T cells 
produced dose-dependent activation of a Rac1 biosensor (fig. S27), and fibroblasts stably 
expressing uniRapR-Vav2 or uniRapR-ITSN produced protrusions and ruffles upon 
rapamycin addition (fig. S27 and movie S9).
Successful photo-inhibition suggested that we might also use allosteric control to activate 
proteins with light. GEFs, and many other proteins, are regulated by intramolecular 
interactions of autoinhibitory domains (AID), which might be turned on and off 
allosterically. Analyzing the CH portion of Vav2’s AID showed two potential insertion loops 
(Fig. 4A and fig. S28). We inserted LOV2 in these and in three additional loops not 
predicted to control activity (fig. S29). In live cell assays using Rac1 biosensor activity as a 
readout, only the computed insertion sites produced robust switches (Fig. 4B and fig. S29). 
In fibroblasts, Vav2 photo-activation induced rounding and lamellae formation rather than 
the retractions produced by photo-inhibition. Upon removal of light, PA-Vav2 cells 
underwent marked contractions (panels 1 and 2 in Fig. 4C; fig. S30; movie S10). These 
results demonstrated that a protein can be allosterically activated by light through control of 
its AID.
With optogenetics, effects of protein manipulation can be assayed rapidly, before the cell has 
a chance to compensate as it does with genetic manipulations. We tested whether 
photoactivation and photoinhibition could be combined, to assay how photoactivation of one 
protein is affected by downstream inhibition of another. Unlike the rounding and large 
lamellae produced by irradiating PA-Vav2 (panel 1 in Fig. 4C and movie S10), irradiating 
PI-Rac1 cells (produced via knockdown/rescue of Rac1) caused retraction (panels 4 and 5 in 
Fig. 4C and movie S5), with formation of a complex perimeter and increased velocity of 
both retractions and protrusions (panel 6 in Fig. 4C). When PA-Vav2 and PI-Rac1 were 
irradiated in the same cell, area and roundness responded similarly to PA-Vav2 alone, but the 
cell edge showed a phenotype clearly different from that produced by the individual 
proteins, with a strong reduction in edge dynamics during irradiation (panels 7–9 in Fig. 4C, 
movie S11, fig. S30). Thus PI-Rac1 was being activated and affecting results of Vav2 
activation. Interpretation will require further study, but these results are consistent with 
recent work showing that Vav2 can act independent of Rac1 (28–30).
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In summary, we have controlled proteins with light or small molecules in living cells by 
harnessing order/disorder transitions. Sensory domains were inserted into ‘tight’, non-
conserved, surface loops that are allosterically coupled to active sites. Engineered proteins 
switched between naturally occurring, physiologically relevant active and inactive states, 
generating effective tools to manipulate living cells.
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Fig. 1. Design concept and PI-Src
(A) Domains conferring either photo-inhibition (LOV2) or activation induced by small 
molecules (uniRapR) function at the same allosteric site. (B) The termini of LOV2 and 
uniRapR domains are closely spaced for insertion. (C) Paxillin phosphorylation assays show 
that PI-Src’s catalytic activity is inhibited upon irradiation. SYF cells expressing PI-Src(YF) 
show reduced phosphoylation of cell lysates blotted with anti-pTyr antibody. Blue denotes 
irradiation. Error bars show s.e.m (n=3). (D) Inactive (blue) and active (gray) conformations 
of WT Src. The red circle (L) is the insertion site. Conformational changes were quantified 
by displaying the pairwise distance changes (Δd) between all residues as a heat map. The 
upper left triangle shows distances for WT Src, computed from published crystal structures. 
The lower triangle shows distances for PI-Src, determined using molecular dynamics 
simulations of the dark and lit states. Blue = decreased distance, red = increased distance. 
(E) In SYF cells, irradiation causes PI-Src(WT) to translocate to focal adhesions (FA, red 
arrows), edge movements to increase, and cells to polarize and translocate. When cells are 
returned to the dark, FA translocation is reversed but effects on morphodynamics persist. 
(blue = irradiation, n= 18 cells, quantitation in fig. S7)
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Fig. 2. Designing PI-GTPases
(A) Sequence conservation, surface exposure, loop “tightness”, and contact maps were used 
to select insertion loops (fig. S9). Orange filled boxes indicate loops fulfilling selection 
criteria (red dashed lines = thresholds, SS = secondary structure). Lines extending 
perpendicular to the diagonal indicate loops (L) that connect tightly interacting elements of 
secondary structure. When these lines reached the active site (green bands) the loop was 
selected for testing. For PI-Rac1, we selected L1, which connects strands of the β-pleated 
sheet in the interswitch region. (B) GTPase activity in HEK293T cells reported using 
biosensors fused to PI-GTPases in a high throughput assay. gray = dark state mutant, blue = 
lit state mutant, red = T17N (Rac1 and Cdc42) and T19N (RhoA) dominant negative 
mutants, green = wild type GTPase positive control. CFP x axis indicates expression level of 
biosensor-GTPase fusion. Error bars show s.e.m (n=3). (C) (Left) Crystal structure of PI-
Rac1 with interacting proteins (gray mesh); (right) structures of wild type Rac1 (gray) and 
PI-Rac1 (red) are in excellent agreement. L1 loop is the LOV2 insertion loop. (D) Map 
showing inter-residue distances for WT Rac1 versus PI-Rac1, suggesting that these 
molecules undergo similar conformational changes.
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Fig. 3. Designing PI-GEFs
(A) Computational analysis of the Vav2 catalytic DH domain. (Left) black and red boxes 
indicate local and non-local interactions (fig. S9) that mediate coupling between loops and 
the active site. (Right) structural model of the Vav2 DH domain showing insertion loops and 
the active site (green). (B) In living cells, PI-Vav2 was inhibited in the lit state. DM and LM 
= dark and lit mutants. EA = E200A/K333A dominant negative mutant. Error bars show 
s.e.m (n=3). (C) (Left) Reversible retraction induced by irradiation of PI-Vav2 in HeLa cells 
(n=9); retraction = red arrow, protrusion = black arrow. (D) High content live cell imaging 
showed that PI-ITSN was inhibited in the lit state. EA = E1244A dominant negative mutant. 
Error bars show s.e.m (n=3). (E) (Left) Crystal structure of PI-ITSN (L2) in complex with 
Cdc42 superimposed on the wild type ITSN:Cdc42 complex. (F) Comparison of deuterium 
exchange (HD/X) results and dynamic coupling computed using molecular dynamics 
simulations. CL2,I corresponds to the correlation coefficient between the motion of the L2 
loop and the motions of each residue. DI-d corresponds to the differences in relative 
deuteration levels in the dark and light.
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Fig. 4. Designing PA-Vav2 and multiplexed control in living cells
(A) (Left) Computational analysis of Vav2’s AID indicated that loops L1 and L2 are coupled 
to the active site (green) through non-local (red box) and local (black box) interactions. CH 
and AC denote calponin-homology and acidic motifs. (Right) A structural model of the AID 
showing the connection of L1 and L2 to the active site. (B) PA-Vav2 is activated in the lit 
state, assayed as in Fig. 2B. Error bars show s.e.m (n=3). (C) Effects of irradiation and 
cessation of irradiation on cells expressing PA-Vav2 alone, PI-Rac1 alone, or both in the 
same cell. Blue box denotes irradiation, ea = edge activity, and envelopes show s.e.m (n= 15 
for PA-Vav2, n= 18 for PI-Rac1, n= 17 for PA-Vav2+PI-Rac1).
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